Clinical Trial Update: A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials [Phase 2]

View source ↗

Summary

Phase 2 study updating the long-term safety and tolerability of darunavir/ritonavir in HIV-1 infected participants who rolled over from other TMC114 trials; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Norvir (ritonavir)
• PREZISTA (darunavir)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: HIV | Phase 2 | Status: COMPLETED